International Laboratories LLC is voluntarily recalling clopidogrel 75 mg tablets due to mislabeling concerns.
Magno-Humphries Laboratories Inc is voluntarily recalling Basic Drugs Brand Senna Laxative tablets due to mislabeling concerns.
The FDA is now requiring new information in the labeling of these products describing the risks of use in children or breastfeeding women.
The manufacturer, Tesaro, recommends that healthcare providers watch for hypersensitivity or anaphylaxis during and following rolapitant administration.
Gadolinium-based contrast agents (GBCAs) can remain in patients’ bodies for months to years after administration.
Archives by Year